Trial Profile
An open-label, single-treatment, single-period, single dose, phase 1 clinical study to assess the safety and tolerability of diphtheria, tetanus, pertussis (whole cell) and haemophilus type b conjugate vaccine of M/s Cadila Healthcare Ltd., India in healthy, adult, male, human subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Hib-DTP vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 19 Mar 2014 New trial record